刘明洋;陈杰;关健;
LIU Ming-yang;CHEN Jie;GUAN Jian;Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院

摘要(Abstract)：

目的研究胆固醇包裹let-7a模拟物(mimics)是否能通过下调人3种Ras抑制肝癌发展,寻找肝癌的潜在治疗策略。方法采用MTT增殖分析、PI单染和Annexin V/FITC双染方法检测let-7a mimics在体外对肝癌细胞的作用。使用裸鼠皮下移植瘤模型和通过肿瘤局部注射方法观察let-7a mimics对体内肝癌的作用。采用实时定量PCR和Western blot方法检测let-7a及其靶点Ras的表达。结果与阴性对照组相比,let-7a mimics转染的肝癌细胞let-7a水平升高,细胞增殖缓慢(P均<0.05);let-7a mimics阻滞更多肝癌细胞停留在G0-G1期且促进肝癌细胞凋亡(P均<0.05)。经let-7a mimics治疗的裸鼠体内肿瘤体积较阴性对照组减小,是阴性对照组的54.97%(P=0.039);局部浸润和肝脏转移较阴性对照组明显减轻。肝癌细胞和移植瘤组织内let-7a上调的同时,人K-Ras、H-Rras和N-Ras mRNA和蛋白的表达降低(P均<0.05)。结论 let-7a mimics下调人3种Ras mRNA和蛋白的表达,影响细胞周期,进而抑制细胞增殖和促进细胞凋亡。瘤周多点注射胆固醇包裹的let-7a mimics能抑制移植瘤的生长、浸润和转移。提示let-7阻断Ras可成为肝癌治疗的研究策略。
Objective To investigate the potential antitumor effects of cholesterol-conjugated let-7a mimics( let-7a mimics) on hepatocellular carcinoma( HCC) by down-regulating all 3 human Ras,with the aim to explore alternative therapeutic strategy for HCC. Methods Effects of let-7a mimics on HCC cells in vitro were detected using MTT-based cell proliferation assays in combination with propidium iodide staining and annexin-V /FITC double staining. The antitumor effects in vivo of let-7a mimics on HCC growth were analyzed in subcutaneous xenograft nude mice with intra-tumoral injections. Expressions of let-7a and its target human Ras were examined with real-time PCR and Western blot. Results let-7a mimics-transfected HCC cells showed increased let-7a levels and slower proliferation compared with the negative controls( both P < 0. 05). let-7a mimics induced more cell-cycle arrest at the G0-G1 phase and promoted apoptosis of HCC cells( both P < 0. 05). In addition,significant reductions in tumor size,local invasion and metastasis to liver were observed in let-7a mimics-treated nude mice compared to negative controls. The tumor size after let-7a treatment was 54. 97% that of negative controls( P = 0. 039). Furthermore,the up-regulation of let-7a coincided with the reduction of K-Ras,H-Rras,and N-Ras mRNA and protein expressions in HCC cells and xenograft tumor( all P < 0. 05). Conclusions let-7a mimics could affect cell cycle,inhibit cell proliferation and promote cell apoptosis by downregulation of mRNA and protein expressions of all the 3 human Ras. Local injections of cholesterol-conjugated let-7a mimics could effectively suppress the growth,invasion and metastasis of xenograft tumor. These findings suggest that Ras-targeting let-7 mimics could be a potential therapeutic option for HCC.

关键词(KeyWords)： 肝癌;let-7a;K-Ras;H-Ras;N-Ras;细胞周期;局部注射治疗
hepatocellular carcinoma;let-7a;K-Ras;H-Ras;N-Ras;cell cycle;local injection treatment

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 刘明洋;陈杰;关健;
LIU Ming-yang;CHEN Jie;GUAN Jian;Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College;

参考文献(References)：

• [1]Aravalli RN,Steer CJ,Cressman EN.Molecular mechanisms of hepatocellular carcinoma[J].Hepatology,2008,48:2047-2063.
• [2]Wei KR,Yu X,Zheng RS,et al.Incidence and mortality of liver cancer in China,2010[J].Chin J Cancer,2014,33:388-394.
• [3]Lai EC.MicroRNAs are complementary to 3'UTR sequence motifs that mediate negative post-transcriptional regulation[J].Nat Genet,2002,30:363-364.
• [4]Calin GA,Sevignani C,Dumitru CD.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J].Proc Natl Acad,2004,101:2999-3004.
• [5]Calin GA,Croce CM.MicroRNA signatures in human cancers[J].Nat Rev Cancer,2006,6:857-866.
• [6]Lee RC,Feinbaum RL,Ambros V.The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell,1993,75:843-854.
• [7]Reinhart BJ,Slack FJ,Basson M.The 21-nucleotide let-7RNA regulates developmental timing in Caenorhabditis elegans[J].Nature,2000,403:901-906.
• [8]Roush S,Slack FJ.The let-7 family of microRNAs[J].Trends Cell Biol,2008,18:505-516.
• [9]Kumar MS,Erkeland SJ,Pester RE,et al.Suppression of non-small cell lung tumor development by the let-7 microRNA family[J].Proc Natl Acad Sci USA,2008,105:3903-3908.
• [10]He XY,Chen JX,Zhang Z,et al.The let-7a microRNA protects from growth of lung carcinoma by suppression of K-Ras and c-Myc in nude mice[J].J Cancer Res Clin Oncol,2010,136:1023-1028.
• [11]Torrisani J,Bournet B,du Rieu MC,et al.let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression[J].Hum Gene Ther,2009,20:831-844.
• [12]Appari M,Babu KR,Kaczorowski A,et al.Sulforaphane,quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-Ras inhibition[J].Int J Oncol,2014,45:1391-1400.
• [13]Jin H,Lv S,Yang J,et al.Use of microRNA let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells[J].PLo S One,2011,6:e21307.
• [14]Johnson CD,Esquela-Kerscher A,Stefani G,et al.The let-7microRNA represses cell proliferation pathways in human cells[J].Cancer Res,2007,67:7713-7722.
• [15]Johnson SM,Grosshans H,Shingara J,et al.RAS is regulated by the let-7 microRNA family[J].Cell,2005,120:635-647.
• [16]Tsang WP,Kwok TT.let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3[J].Apoptosis,2008,13:1215-1222.
• [17]Chen KJ,Hou Y,Wang K,et al.Reexpression of let-7g microRNA inhibits the proliferation and migration via K-Ras/HMGA2/snail axis in hepatocellular carcinoma[J].Biomed Res Int,2014,2014:742417.
• [18]Calvisi DF,Ladu S,Gorden A,et al.Ubiquitous activation of Ras and Jak/Stat pathways in human HCC[J].Gastroenterology,2006,130:1117-1128.
• [19]Calvisi DF,Ladu S,Conner EA,et al.Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer[J].J Hepatol,2011,54:311-319.
• [20]Zhu XM,Wu LJ,Xu J,et al.let-7c microRNA expression and clinical significance in hepatocellular carcinoma[J].J Int Med Res,2011,39:2323-2329.
• [21]Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DeltaDelta C(T))Method[J].Methods,2001,25:402-408.
• [22]Shields JM,Pruitt K,Mc Fall A.Understanding Ras:‘it ain't over til it's over’[J].Trends Cell Biol,2000,10:147-154.
• [23]Marshall C.How do small GTPase signal transduction pathways regulate cell cycle entry?[J].Curr Opin Cell Biol,1999,11:732-736.
• [24]Downward J.Cancer biology:signatures guide drug choice[J].Nature,2006,439:274-275.
• [25]Schubbert S,Shannon K,Bollag G.Hyperactive Ras in developmental disorders and cancer[J].Nat Rev Cancer,2007,7:295-308.
• [26]Bussing I,Slack FJ,Grosshans H.let-7 microRNAs indevelopment,stem cells and cancer[J].Trends Mol Med,2008,14:400-409.
• [27]Boyerinas B,Park SM,Hau A,et al.The role of let-7 in cell differentiation and cancer[J].Endocr Relat Cancer,2010,17:F19-F36.
• [28]Roush S,Slack FJ.The let-7 family of microRNAs[J].Trends Cell Biol,2008,18:505-516.
• [29]Callegari E,Elamin BK,Sabbioni S,et al.Role of microRNAs in hepatocellular carcinoma:a clinical perspective[J].Onco Targets Ther,2013,6:1167-1178.
• [30]Hou J,Lin L,Zhou W,et al.Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma[J].Cancer Cell,2011,19:232-243.
• [31]Giordano S,Columbano A.MicroRNAs:new tools for diagnosis,prognosis,and therapy in hepatocellular carcinoma?[J].Hepatology,2013,57:840-847.
• [32]Liu YM,Xia Y,Dai W,et al.Cholesterol-conjugated let-7a mimics:antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy[J].BMC Cancer,2014,14:889.